• Heterogeneity and temporal variation in the management of COVID-19: a multinational drug utilization study including 71,921 hospitalized patients from China, South Korea, Spain, and the United States of America 

  Prats-Uribe, A; Sena, A; Hui Lai, LY; Ahmed, W-U-R; Alghoul, H; Alser, O; Alshammari, T; Areia, C; Carter, W; Casajust, P; ... (2020-09-18)

  <h4>Objectives</h4> A plethora of medicines have been repurposed or used as adjunctive therapies for COVID-19. We characterized the utilization of medicines as prescribed in routine practice amongst patients hospitalized ...

• Risk of depression, suicidal ideation, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort study 

  Lane, JCE; Weaver, J; Kostka, K; Duarte-Salles, T; Abrahao, MT; Alghoul, H; Alser, O; Alshammari, T; Areia, C; Biedermann, P; ... (2020-07-21)

  <h4>ABSTRACT</h4> <h4>Objectives</h4> Concern has been raised in the rheumatological community regarding recent regulatory warnings that hydroxychloroquine used in the COVID-19 pandemic could cause acute psychiatric events. ...

• Seek COVER: Development and validation of a personalized risk calculator for COVID-19 outcomes in an international network 

  Williams, R; Markus, A; Yang, C; Salles, TD; DuVall, S; Falconer, T; Jonnagaddala, J; Kim, C; Rho, Y; Williams, A; ... (2020-05-27)

  <h4>Objective</h4> To develop and externally validate COVID-19 Estimated Risk (COVER) scores that quantify a patient’s risk of hospital admission (COVER-H), requiring intensive services (COVER-I), or fatality (COVER-F) in ...

View more